期刊文献+

112例鼻腔NK/T细胞淋巴瘤的预后分析 被引量:5

Prognostic factors analysis of nasal NK/T cell lymphoma
下载PDF
导出
摘要 目的回顾分析影响鼻腔NK/T细胞淋巴瘤预后的因素。方法搜集2010~2017年收治的鼻腔NK/T细胞淋巴瘤患者112例,采用Kaplan-Meier法进行单因素生存分析并进行Cox多因素分析。结果全组5年样本数24例,1年、3年、5年生存率分别为92%、72%、54%。单因素分析显示年龄、性别、白蛋白水平、Ki-67阳性率、治疗模式(放疗、化疗、放化疗联合)、首发症状至确诊时间、首次治疗完全缓解与鼻腔NK/T细胞淋巴瘤的预后相关。多因素分析显示症状首次出现时间至确诊时间及Ki-67阳性率大于50%为影响鼻腔NK/T淋巴瘤预后的独立危险因素。结论症状首次出现时间至确诊时间及Ki-67阳性率可作为评价鼻腔NK/T淋巴瘤预后的参考因素。 OBJECTIVE To investigate the prognosis of nasal NK/T cell lymphoma. METHODS The clinical data of 112 patients with a primary diagnosis of nasal NK/T cell lymphoma treated at the First Hospital of Zhengzhou University between January 2010 and June 2017 were studied. The association between clinical parameters and survival rate was evaluated by Kaplan-Meier method and Cox regression model. RESULTS The 1-, 3-, 5-year overall survival were 92%, 72% and 54% respectively. Single factor analysis displayed that age, gender, the level of albumin, the expression level of Ki-67, treatment model, complete response rate to the primary treatment and the interval between symptom onset to diagnosis were related to the prognosis factors. Multivariate analysis showed that the interval of first time of symptom onset to the time of diagnosis and the positive rate of Ki-67 more than 50% were the independent risk factors for the prognosis of nasal NK/T lymphoma. CONCLUSION The interval of symptom onset to the time of diagnosis and the positive rate of Ki-67 may be independent prognostic factors for NK/T cell lymphoma.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2017年第11期593-596,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
关键词 淋巴瘤 结外NK-T细胞 鼻腔 预后 KI-67抗原 Lymphoma, Extranodal NK-T-CelI Nasal Cavity Prognosis Ki-67 Antigen
  • 相关文献

参考文献2

二级参考文献32

  • 1Harris NL,Jaffe ES,Diebold J,et al.The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues:Report of the Clinical Advisory Committee Meeting,Airlie House,Virginia,November 1997.Histopathology,2000,36(1):69-86.
  • 2Cheung MM,Chan JK,Lau WH,et al.Early stage nasal NK/T-cell lymphoma:clinical outcome,prognostic factors,and the effect of treatment modality.Int J Radiat Oncol Biol Phys,2002,54(1):182-190.
  • 3Carbone PP,Kaplan HS,Musshoff K,et al.Report of the Committee on Hodgkin's Disease Staging Classification.Cancer Res,1971,31(11):1860-1861.
  • 4Oken MM,Creech RH,Tormey DC,et al.Toxicity and response criteria of the Eastern Cooperative Oncology Group.Am J Clin Oncol,1982,5(6):649-655.
  • 5A predictive model for aggressive non-Hodgkin's lymphoma.The International Non-Hodgkin' s Lymphoma Prognostic Factors Project.N Engl J Med,1993,329(14):987-994.
  • 6Cheson BD,Homing SJ,Coiffier B,et al.Report of an intemational workshop to standardize response criteria for nonHodgkin's lymphomas.NCI Sponsored International Working Group.J Clin Oncol,1999,17(4):1244.
  • 7You JY,Chi KH,Yang MH,et al.Radiation therapy versus chemotherapy as initial treatment for localized nasal natural killer (NK)/T-cell lymphoma:a single institute survey in Taiwan.Ann Oncol,2004,15(4):618-625.
  • 8Kim WS,Song SY,Ahn YC,et al.CHOP followed by involved field radiation:is it optimal for localized nasal natural killer/T-cell lymphoma?.Ann Oncol,2001,12(3):349-352.
  • 9Takahashi E,Ohshima K,Kimura H,et al.Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.Histopathology,2011,59 (4):660-671.
  • 10Kwong YL.Natural killer-cell malignancies:diagnosis and treatment.Leukemia,2005,19(12):2186-2194.

共引文献10

同被引文献26

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部